SOURCE: BIOLASE Technology, Inc.

September 21, 2006 12:34 ET

BIOLASE to Present at UBS Global Life Sciences Conference

Live Web Cast: September 26, 2006 at 2:30 p.m. Eastern Time

IRVINE, CA -- (MARKET WIRE) -- September 21, 2006 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that President and CEO Jeffrey W. Jones and CFO Richard L. Harrison are scheduled to make an investor presentation at the UBS Global Life Sciences Conference at 2:30 p.m. (Eastern) on Tuesday, September 26.

The presentation will be accessible by live web cast on the investor relations section of BIOLASE's web site at www.biolase.com. A replay of the web cast will be available on BIOLASE's web site for 60 days.

The Conference is being held September 25-28 at the Grand Hyatt New York in New York City.

About BIOLASE Technology, Inc.

BIOLASE Technology, Inc. (http://www.biolase.com) is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine. The Company's products incorporate patented and patent pending technologies focused on reducing pain and improving clinical results. Its primary product, the Waterlase® system, is one of the best selling dental laser systems. The Waterlase system uses a patented combination of water and laser to precisely cut hard tissue, such as bone and teeth, and soft tissue, such as gums, with minimal or no damage to surrounding tissue. The Company also offers the LaserSmile™ system, which uses a laser to perform soft tissue and cosmetic procedures, including teeth whitening. The Company is also developing a laser for use in the field of ophthalmology.

This press release may contain forward-looking statements within the meaning of safe harbor provided by the Securities Reform Act of 1995 that are based on the current expectations and estimates by our management. These forward-looking statements can be identified through the use of words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," "may," "will," and variations of these words or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks, uncertainties and other factors which may cause the Company's actual results to differ materially from the statements contained herein, and are described in the company's reports it files with the Securities and Exchange Commission, including its annual and quarterly reports. No undue reliance should be placed on forward-looking statements. Such information is subject to change, and we undertake no obligation to update such statements.

Contact Information

  • For further information, please contact:
    Jeffrey W. Jones
    President & CEO

    Richard L. Harrison
    Executive Vice President and CFO

    Scott Jorgensen
    Vice President - Business Development

    BIOLASE Technology, Inc.
    +1-949-361-1200